FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2622477029> ?p ?o ?g. }

• W2622477029 abstract "Short QT syndrome (SQTS) is a newly identified clinical disorder associated with atrial and/or ventricular arrhythmias and increased risk of sudden cardiac death (SCD). The SQTS variant 3 is linked to D172N mutation to the KCNJ2 gene that causes a gain-of-function to the inward rectifier potassium channel current (I K1), which shortens the ventricular action potential duration (APD) and effective refractory period (ERP). Pro-arrhythmogenic effects of SQTS have been characterized, but less is known about the possible pharmacological treatment of SQTS. Therefore, in this study, we used computational modeling to assess the effects of amiodarone, class III anti-arrhythmic agent, on human ventricular electrophysiology in SQT3.The ten Tusscher et al. model for the human ventricular action potentials (APs) was modified to incorporate I K1 formulations based on experimental data of Kir2.1 channels (including WT, WT-D172N and D172N conditions). The modified cell model was then implemented to construct one-dimensional (1D) and 2D tissue models. The blocking effects of amiodarone on ionic currents were modeled using IC50 and Hill coefficient values from literatures. Effects of amiodarone on APD, ERP and pseudo-ECG traces were computed. Effects of the drug on the temporal and spatial vulnerability of ventricular tissue to genesis and maintenance of re-entry were measured, as well as on the dynamic behavior of re-entry.Amiodarone prolonged the ventricular cell APD and decreased the maximal voltage heterogeneity (δV) among three difference cells types across transmural ventricular wall, leading to a decreased transmural heterogeneity of APD along a 1D model of ventricular transmural strand. Amiodarone increased cellular ERP, prolonged QT interval and decreased the T-wave amplitude. It reduced tissue's temporal susceptibility to the initiation of re-entry and increased the minimum substrate size necessary to sustain re-entry in the 2D tissue.At the therapeutic-relevant concentration of amiodarone, the APD and ERP at the single cell level were increased significantly. The QT interval in pseudo-ECG was prolonged and the re-entry in tissue was prevented. This study provides further evidence that amiodarone may be a potential pharmacological agent for preventing arrhythmogenesis for SQT3 patients." @default.
• W2622477029 created "2017-06-15" @default.
• W2622477029 creator A5043271142 @default.
• W2622477029 creator A5049558861 @default.
• W2622477029 creator A5074181962 @default.
• W2622477029 date "2017-06-07" @default.
• W2622477029 modified "2023-10-15" @default.
• W2622477029 title "Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study" @default.
• W2622477029 cites W1505612411 @default.
• W2622477029 cites W1524713415 @default.
• W2622477029 cites W1586340968 @default.
• W2622477029 cites W1824551304 @default.
• W2622477029 cites W1912682098 @default.
• W2622477029 cites W1965633790 @default.
• W2622477029 cites W1966776959 @default.
• W2622477029 cites W1967019376 @default.
• W2622477029 cites W1967867484 @default.
• W2622477029 cites W1973160752 @default.
• W2622477029 cites W1977098804 @default.
• W2622477029 cites W1988498011 @default.
• W2622477029 cites W2006196596 @default.
• W2622477029 cites W2007825638 @default.
• W2622477029 cites W2026247776 @default.
• W2622477029 cites W2045548568 @default.
• W2622477029 cites W2046508051 @default.
• W2622477029 cites W2049255562 @default.
• W2622477029 cites W2051248612 @default.
• W2622477029 cites W2058755860 @default.
• W2622477029 cites W2076845323 @default.
• W2622477029 cites W2077203000 @default.
• W2622477029 cites W2081864503 @default.
• W2622477029 cites W2089861793 @default.
• W2622477029 cites W2101203342 @default.
• W2622477029 cites W2101393483 @default.
• W2622477029 cites W2103583385 @default.
• W2622477029 cites W2107658445 @default.
• W2622477029 cites W2110010005 @default.
• W2622477029 cites W2114296544 @default.
• W2622477029 cites W2115765852 @default.
• W2622477029 cites W2120263248 @default.
• W2622477029 cites W2129393568 @default.
• W2622477029 cites W2132249803 @default.
• W2622477029 cites W2133315076 @default.
• W2622477029 cites W2138895639 @default.
• W2622477029 cites W2144148024 @default.
• W2622477029 cites W2146438418 @default.
• W2622477029 cites W2147836600 @default.
• W2622477029 cites W2153116368 @default.
• W2622477029 cites W2154806697 @default.
• W2622477029 cites W2154876398 @default.
• W2622477029 cites W2160235532 @default.
• W2622477029 cites W2160851716 @default.
• W2622477029 cites W2161424604 @default.
• W2622477029 cites W2163071496 @default.
• W2622477029 cites W2167858546 @default.
• W2622477029 cites W2171018904 @default.
• W2622477029 cites W2323975388 @default.
• W2622477029 doi "https://doi.org/10.1186/s12938-017-0369-0" @default.
• W2622477029 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5463381" @default.
• W2622477029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28592292" @default.
• W2622477029 hasPublicationYear "2017" @default.
• W2622477029 type Work @default.
• W2622477029 sameAs 2622477029 @default.
• W2622477029 citedByCount "13" @default.
• W2622477029 countsByYear W26224770292018 @default.
• W2622477029 countsByYear W26224770292019 @default.
• W2622477029 countsByYear W26224770292020 @default.
• W2622477029 countsByYear W26224770292021 @default.
• W2622477029 crossrefType "journal-article" @default.
• W2622477029 hasAuthorship W2622477029A5043271142 @default.
• W2622477029 hasAuthorship W2622477029A5049558861 @default.
• W2622477029 hasAuthorship W2622477029A5074181962 @default.
• W2622477029 hasBestOaLocation W26224770291 @default.
• W2622477029 hasConcept C118441451 @default.
• W2622477029 hasConcept C126322002 @default.
• W2622477029 hasConcept C164705383 @default.
• W2622477029 hasConcept C2778094803 @default.
• W2622477029 hasConcept C2779161974 @default.
• W2622477029 hasConcept C2779362680 @default.
• W2622477029 hasConcept C2779578097 @default.
• W2622477029 hasConcept C2779703243 @default.
• W2622477029 hasConcept C71924100 @default.
• W2622477029 hasConcept C83743174 @default.
• W2622477029 hasConceptScore W2622477029C118441451 @default.
• W2622477029 hasConceptScore W2622477029C126322002 @default.
• W2622477029 hasConceptScore W2622477029C164705383 @default.
• W2622477029 hasConceptScore W2622477029C2778094803 @default.
• W2622477029 hasConceptScore W2622477029C2779161974 @default.
• W2622477029 hasConceptScore W2622477029C2779362680 @default.
• W2622477029 hasConceptScore W2622477029C2779578097 @default.
• W2622477029 hasConceptScore W2622477029C2779703243 @default.
• W2622477029 hasConceptScore W2622477029C71924100 @default.
• W2622477029 hasConceptScore W2622477029C83743174 @default.
• W2622477029 hasFunder F4320321001 @default.
• W2622477029 hasIssue "1" @default.
• W2622477029 hasLocation W26224770291 @default.
• W2622477029 hasLocation W26224770292 @default.
• W2622477029 hasLocation W26224770293 @default.
• W2622477029 hasLocation W26224770294 @default.
• W2622477029 hasLocation W26224770295 @default.

• next